Category Archives: People

FDA: From Risk Aversion to Approval Activism

By Ben Comer | Published: May 7, 2013

During the Rutgers Business School’s annual healthcare symposium, an FDA official encouraged industry to put its drugs on the reviewing table and be prepared for good news. On a panel titled “Activist FDA: Transformation Agent,” Prevision Policy founder and former Pink Sheet editorial head Cole Werble relayed the tale of Acadia Pharmaceuticals, a San Diego-based [...]

Also posted in Agency Insight, Biotech, FDA, Legal, Market Access, Orphan Drugs, R&D, Regulatory, Strategy, leadership | Tagged access, breakthrough therapies, CDER, Cole Werble, FDA, IMS, Rachel Sherman, Regulatory | 2 Comments

Ad Agency Encourages Pharma Marketers to Reboot

By Ben Comer | Published: April 16, 2013

People tell you who they are, but we ignore it – because we want them to be who we want them to be. – Don Draper At the beginning of the Reboot Camp – held at New York City’s Alexandria Center on April 12 – Intouch Solutions’ CEO Faruk Capan declared the days of Don Draper [...]

Also posted in Advertising, Agency Insight, Emerging Markets, FDA, Marketing, Patient Communication, Regulatory, Sales, Strategy, Technology, healthcare, leadership, patient education, social media | Tagged Agency, big data, Crossix, digital health, digital marketing, Fitbit, FuelBand, GE Healthcare, Happtique, Intouch Solutions, mHealth, mobile health, Sanofi | 1 Comment

Pharma 2012 Layoffs

By Reid Paul | Published: January 9, 2013

brightcove.createExperiences();

Also posted in Emerging Markets, Europe, Global, Manufacturing, Marketing, News, R&D, Sales, Strategy, Video | Leave a comment

New York Pharma Forum: Together We Stand

By Ben Comer | Published: December 13, 2012

Participants in the 23rd Annual NYPF General Assembly last Friday outlined the many challenges facing industry, and the importance of collaboration as a way to move forward.

Also posted in Biotech, Events, R&D, Strategy, Technology, leadership | Tagged academia, Biotech, collaboration, innovation, Meetings, Merck, New York City, New York Pharma Forum, NYPF, partnerships, Pharma, Takeda | Leave a comment

Pharma in the Dell: Working with Academia

By Ben Comer | Published: November 14, 2012

How can the emerging field of data science help to fruitfully translate research and discovery into successful drug development? Academics and pharmaceutical executives at Mount Sinai’s School of Medicine discussed ways to build a bridge across the valley of death, and the growing importance of data across all business areas.

Also posted in Biotech, Deals, IP, Meetings, R&D, Strategy, Technology, leadership | Tagged Celera, Data, Gilead, Intellectual property, Janssen, Mount Sinai School of Medicine, Pfizer | Leave a comment